DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,255 | +105.5% | 55,196 | +100.0% | 0.00% | – |
| Q2 2023 | $329,520 | -10.7% | 27,598 | 0.0% | 0.00% | – |
| Q1 2023 | $368,985 | -63.0% | 27,598 | -40.4% | 0.00% | -100.0% |
| Q4 2022 | $997,065 | +9.7% | 46,332 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $909,000 | +9.7% | 46,332 | -0.0% | 0.00% | 0.0% |
| Q2 2022 | $829,000 | +123.5% | 46,333 | +23.7% | 0.00% | – |
| Q1 2022 | $371,000 | -41.2% | 37,449 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $631,000 | +57.8% | 37,449 | +122.2% | 0.00% | – |
| Q3 2021 | $400,000 | 0.0% | 16,856 | 0.0% | 0.00% | – |
| Q2 2021 | $400,000 | – | 16,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |